We love our bottoms-up scans here at All Star Charts. We tend to get really creative when making new universes as we want to be sure they will deliver us the best opportunities the market has to...
Biotech has been one of the worst-performing industry groups this cycle. Investors have got used to it as these stocks have been dead money for much of the past decade.
Today's trade is in a big cap leader that has been in a little drawdown off highs over the past couple of weeks. This, coupled with earnings coming up next week has options premiums juiced.
It doesn’t matter if it’s a new trading strategy, a new instrument—like moving from stocks to options or options to futures—or a new way of doing research… newness brings discomfort. It’s awkward. You don’t know what...
I've been loving how this boring utility space name has been consolidating near all-time highs since February. Most people have probably been bored to tears if they've been in it. Longs are comfortable, shorts are asleep. Great.
